Companies › TCRG

TCRG 10-K & 10-Q changes, risk factors and insider trading

Cannaisseur Group Inc. · OTC · Medicinal Chemicals & Botanical Products · CIK 1879270 · All filings on SEC.gov

Everything below is quoted or computed from Cannaisseur Group Inc.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

0 / 0risk-factor paragraphs added / removed in latest 10-K
0new risk-factor headings
0Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparing 10-K filed 2026-03-23 (period ending 2025-12-31) with 10-K filed 2025-03-21 (period ending 2024-12-31).

Risk Factors (10-K Item 1A)

0new paragraphs
0removed paragraphs
1reworded paragraphs
6,426 → 6,426words in section
Full comparison: every changed paragraph (1)

Green = added, red = removed. Unchanged paragraphs, 1 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

We have filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission (“SEC”). -WeWe are subject to to the reporting requirements of the Exchange Act and the other rules and regulations of the SEC relating to public companies. We are working working with independent legal, accounting and financial advisors to identify those areas in which changes should be made to our financial and management control systems to manage our growth and our obligations as an SEC reporting company. These areas include corporate governance, internal control, internal audit, disclosure controls and procedures and financial reporting and accounting systems. We have made, and will continue to make, changes in these and other areas, including our internal control over financial reporting. However, we cannot provide assurances that these and other measures we may take will be sufficient to allow us to satisfy our obligations as an SEC reporting company on a timely basis.

Management's Discussion & Analysis (MD&A) (10-K Item 7)

3new paragraphs
3removed paragraphs
6reworded paragraphs
2,814 → 2,791words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Removed text
“For the twelve months ended December 31, 2024, cash used in operating activities of $110,627 resulted from a net loss of $1,273,006, adjustments for non-cash items totaling $1,042,000 and a net increase of $120,379 in the components of working capital. The non-cash adjustments to net income is attributable to charges of $1,042,000 for share-based compensation. …”
see in full comparison
New text
“For the twelve months ended December 31, 2024, cash used in operating activities of $110,627 resulted from a net loss of $1,273,006, adjustments for non-cash items totaling and a net increase of $120,379 in the components of working capital. The non-cash adjustments to net income is attributable to charges of $1,042,000 for share-based compensation. …”
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

As of December 31, 2025, we had total liabilities of $235,431, including accounts payable and accrued expenses of $192,162, settlement payable of $9,501, dividends payable of $1,608, notes payable current of $7,361, and long-term notes payable of $24,799. As of December 31, 2024, we had total liabilities of $305,576, consisting of accounts payable and accrued expenses of $169,807, settlement payable of $9,501, notes payable - current of $46,697, dividends payable of $1,608, and long-term notes payable of $76,463. As of December 31, 2023, we had total liabilities of $136,687, including accounts payable and accrued expenses of $47,918, settlement payable of $15,001, dividends payable of $1,608, notes payable current of $6,377, and long-term notes payable of $65,783. The increasedecrease in liabilities is is mainly due to ana increasedecrease in accounts payable and accrued expenses and additional convertible notes payable.payable – related parties.
see in full comparison
Removed text
“Other expense, net was $6,427 during the twelve months ended December 31, 2024, compared to other income, net of $17,314 during the twelve months ended December 31, 2023, a change of $23,741, or 137.1%. The change was the result of a gain on settlement for accrued rent payable, as well as a decrease in interest expense during the twelve months ended December 31, 2023. During the year ended December 31, 2024, other expense, net consisted entirely of interest expense.”
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

For the twelve months ended December 31, 2023,2025, cash used in operating activities of $126,074$127,451 resulted primarily from a net loss of $172,586$1,808,379 adjusted for non-cash items totaling $339$1,308,619 and a net increase of $46,173 in the components of working capital. The non-cash adjustments to net income are attributable to charges of $15,485$1,292,962 for amortizationshare-based of right of use asset,compensation, gain on settlement of $18,968,accounts payable of $3,800, loss on conversion of related party debt of $23,282, and $3,822 forloss depreciation.on conversion of mezzanine equity of $68,175. The change in the components of working capital was due primarily to an increase in accounts payable and accrued expenses of $63,420 and a decrease in right of use lease liability of $17,124,$299,114, with the remaining change attributable to normal operational fluctuations in current assets and current liabilities.
see in full comparison
Removed text
“For the twelve months ended December 31, 2023, cash provided by financing activities of $145,930 consisted of $91,518 in proceeds from the sale of common stock, $9,378 in proceeds from short term loans offset by repayments of $4,518, contributed capital by related parties of $10,502, proceeds from convertible note payable of $40,000, and repayments of related party debt of $950.”
see in full comparison
Full comparison: every changed paragraph (12)

Green = added, red = removed. Unchanged paragraphs, 4 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

Cost of revenue was $4,275$910 for the twelve months ended December 31, 2024,2025, compared to $26,976$4,275 during the twelve months ended December 31, 2024, 2023, a decrease of $22,701,$3,365, or 84.2%.78.7%. The decrease was driven primarily by reduceda lack of sales in the current year.year and reduced write-off of obsolete inventory.

Reworded

OurThe Company reported negative gross profit for the years ended December 31, 2025 and 2024. The negative profit margins were (510.7%)the result of reduced sales, due to the closing of the Company’s retail store, and 49.2%increases duringin thewrite-offs twelveof monthsobsolete ended December 31, 2024 and 2023, respectively.inventory. Continued growth of the consumer market for CBD products and increases in competition are anticipated to continue to create pressure on gross profit margins.

Reworded

Selling, general and administrative expenses were $1,263,004$1,715,535 for the twelve months ended December 31, 2024,2025, an increase of $1,046,950,$452,531, or 484.6%,35.8%, compared to $216,054$1,263,004 during the twelve months ended December 31, 2023.2024. The increase was driven primarily by an increase in costs associatedstock-based with the registration of shares for sale, an increase in stock-based compensation,compensation and salaries.

Reworded

Other Income (Expense),Expense, Net

Added

Other expense, net was $91,934 during the twelve months ended December 31, 2025, compared to other expense, net of $6,427 during the twelve months ended December 31, 2024, an increase of $85,507, or 1,330.4%. The increase was the result of a loss on conversion of related party debt and loss on conversion of mezzanine equity during the twelve months ended December 31, 2025.

Removed

Other expense, net was $6,427 during the twelve months ended December 31, 2024, compared to other income, net of $17,314 during the twelve months ended December 31, 2023, a change of $23,741, or 137.1%. The change was the result of a gain on settlement for accrued rent payable, as well as a decrease in interest expense during the twelve months ended December 31, 2023. During the year ended December 31, 2024, other expense, net consisted entirely of interest expense.

Reworded

As of December 31, 2025, we had total liabilities of $235,431, including accounts payable and accrued expenses of $192,162, settlement payable of $9,501, dividends payable of $1,608, notes payable current of $7,361, and long-term notes payable of $24,799. As of December 31, 2024, we had total liabilities of $305,576, consisting of accounts payable and accrued expenses of $169,807, settlement payable of $9,501, notes payable - current of $46,697, dividends payable of $1,608, and long-term notes payable of $76,463. As of December 31, 2023, we had total liabilities of $136,687, including accounts payable and accrued expenses of $47,918, settlement payable of $15,001, dividends payable of $1,608, notes payable current of $6,377, and long-term notes payable of $65,783. The increasedecrease in liabilities is is mainly due to ana increasedecrease in accounts payable and accrued expenses and additional convertible notes payable.payable – related parties.

Removed

For the twelve months ended December 31, 2024, cash used in operating activities of $110,627 resulted from a net loss of $1,273,006, adjustments for non-cash items totaling $1,042,000 and a net increase of $120,379 in the components of working capital. The non-cash adjustments to net income is attributable to charges of $1,042,000 for share-based compensation. The change in the components of working capital was due primarily to an increase in accounts payable and accrued expenses of $121,889 and a decrease in the settlement payable liability of $5,500, with the remaining change attributable to normal operational fluctuations in current assets and current liabilities.

Reworded

For the twelve months ended December 31, 2023,2025, cash used in operating activities of $126,074$127,451 resulted primarily from a net loss of $172,586$1,808,379 adjusted for non-cash items totaling $339$1,308,619 and a net increase of $46,173 in the components of working capital. The non-cash adjustments to net income are attributable to charges of $15,485$1,292,962 for amortizationshare-based of right of use asset,compensation, gain on settlement of $18,968,accounts payable of $3,800, loss on conversion of related party debt of $23,282, and $3,822 forloss depreciation.on conversion of mezzanine equity of $68,175. The change in the components of working capital was due primarily to an increase in accounts payable and accrued expenses of $63,420 and a decrease in right of use lease liability of $17,124,$299,114, with the remaining change attributable to normal operational fluctuations in current assets and current liabilities.

Added

For the twelve months ended December 31, 2024, cash used in operating activities of $110,627 resulted from a net loss of $1,273,006, adjustments for non-cash items totaling and a net increase of $120,379 in the components of working capital. The non-cash adjustments to net income is attributable to charges of $1,042,000 for share-based compensation. The change in the components of working capital was due primarily to an increase in accounts payable and accrued expenses of $121,889 and a decrease in the settlement payable liability of $5,500, with the remaining change attributable to normal operational fluctuations in current assets and current liabilities.

Added

For the twelve months ended December 31, 2025, cash provided by financing activities of $126,910 consisted of $90,000 in proceeds from the sale of common stock, contributed capital by related parties of $38,410, and repayments of short-term related party debt of $1,500.

Removed

For the twelve months ended December 31, 2023, cash provided by financing activities of $145,930 consisted of $91,518 in proceeds from the sale of common stock, $9,378 in proceeds from short term loans offset by repayments of $4,518, contributed capital by related parties of $10,502, proceeds from convertible note payable of $40,000, and repayments of related party debt of $950.

What changed in the latest 10-Q

Comparing 10-Q filed 2026-08-12 (period ending 2026-06-30) with 10-Q filed 2026-05-11 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

0new paragraphs
0removed paragraphs
0reworded paragraphs
25 → 25words in section

The section in the latest 10-Q reads in full:

See the Company’s Registration Statement on Form S-1 (File No. 333-262710) for the Risk Factors applicable to the Company and its securities.

No wording changes found in this section.

Full comparison: every changed paragraph (0)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

10new paragraphs
0removed paragraphs
13reworded paragraphs
2,464 → 2,707words in section

New heading “Results of Operations for the Six Months Ended June 30, 2026 Compared with the Six Months Ended June 30, 2025”

New heading “Costs of Revenue”

New heading “Selling, General and Administrative Expenses”

New heading “Other Expense, Net”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text
“Results of Operations for the Six Months Ended June 30, 2026 Compared with the Six Months Ended June 30, 2025”
see in full comparison
New text
“Selling, General and Administrative Expenses”
see in full comparison
New text
“Other Expense, Net”
see in full comparison
New text
“Costs of Revenue”
see in full comparison
New text
“Cost of revenue was $118 for the six months ended June 30, 2026, compared to $446 during the six months ended June 30, 2025, a decrease of $328, or 73.5%. Cost of revenue consisted entirely of the write off of obsolete inventory. The decrease in the current period was the result of less obsolete inventory.”
see in full comparison
New text
“Selling, general and administrative expenses were $196,965 for the six months ended June 30, 2026, compared to $924,115 during the six months ended June 30, 2025, a decrease of $727,150, or 78.7%. The decrease was driven primarily by a decrease in share-based compensation”
see in full comparison
Full comparison: every changed paragraph (23)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

Results of Operations for the Three Months Ended MarchJune 31,30, 2026 Compared with the Three Months Ended MarchJune 31,30, 2025

Reworded

Revenue was $0 for the three months ended March 31,June 30, 2026 and 2025. The Company is not currently operating the retail business. It may, in the future, restructure its website to conduct business online.

Reworded

Cost of revenue was $0$118 for the three months ended MarchJune 31,30, 2026, compared to $164$282 during the three months ended MarchJune 31,30, 2025, a decrease of $164, or 100%.58.2%. The decrease was driven by a lackCost of write-offsrevenue consisted entirely of the write off of obsolete inventoriesinventory. The decrease in the current period.period was the result of less obsolete inventory.

Reworded

The Company reported negative gross profit of $0 for the three months ended MarchJune 31,30, 2026,2026 compared to negative gross profit for the three months ended March 31,and 2025. The negative profit margin was the result of the write-off of obsolete inventory. No obsolete inventory was written off in the current period.

Reworded

Selling, general and administrative expenses were $102,257 $94,708 for the three months ended MarchJune 31,30, 2026, compared to $846,908$77,207 during the three months ended MarchJune 31,30, 2025, aan decreaseincrease of $744,651, $17,501, or 87.9%.22.7%. The decreaseincrease was driven primarily by decreasesan increase in share-basedprofessional compensationfees, expense.such as legal and accounting.

Reworded

Other expense, net was $238$237 during the three months ended June 30, 2026, compared to $1,640 during the three months ended MarchJune 31, 2026, compared to $1,711 during the three months ended March 31,30, 2025, a decrease of $1,473,$1,403, or 86.1%.85.5%. The decrease was the result of reduced interest expense on notes payable.

Added

Results of Operations for the Six Months Ended June 30, 2026 Compared with the Six Months Ended June 30, 2025

Added

Revenue

Added

Revenue was $0 for the six months ended June 30, 2026 and 2025. The Company is not currently operating the retail business. It may, in the future, restructure its website to conduct business online.

Added

Costs of Revenue

Added

Cost of revenue was $118 for the six months ended June 30, 2026, compared to $446 during the six months ended June 30, 2025, a decrease of $328, or 73.5%. Cost of revenue consisted entirely of the write off of obsolete inventory. The decrease in the current period was the result of less obsolete inventory.

Added

The Company reported negative gross profit for the six months ended June 30, 2026 and 2025. The negative profit margin was the result of the write-off of obsolete inventory.

Added

Selling, General and Administrative Expenses

Added

Selling, general and administrative expenses were $196,965 for the six months ended June 30, 2026, compared to $924,115 during the six months ended June 30, 2025, a decrease of $727,150, or 78.7%. The decrease was driven primarily by a decrease in share-based compensation

Added

Other Expense, Net

Added

Other expense, net was $237 during the three months ended June 30, 2026, compared to $1,640 during the three months ended June 30, 2025, a decrease of $1,403, or 85.5%. The decrease was the result of reduced interest expense on notes payable.

Reworded

As of MarchJune 31,30, 2026, the Company had $163$41 in total assets, includingconsisting of cash of $45, as compared to $140 in total assets, including cash of $22, as of December 31, 2025. The increase in assets is attributable to an increase in cash.

Reworded

As of MarchJune 31,30, 2026, the Company had total liabilities of $298,209$362,735 consisting of accounts payable and accrued expenses of $254,940,$319,466, rent settlement payable of $9,501, notes payable - current of $7,531,$7,703, dividends payable of $1,608, and long-term notes payable of $24,629. $24,457. As of December 31, 2025, the Company had total liabilities of $235,431, consisting of accounts payable and accrued expenses of $192,162, settlement payable of $9,501, notes payable - current of $7,361, dividends payable of $1,608, and long-term notes payable of $24,799. The increase in liabilities is mainly due to an increase in accounts payable and accrued expenses.

Reworded

For the threesix months ended MarchJune 31,30, 2026, cash used in operating activities of $39,717$70,136 resulted from a net loss of $102,495 and$197,558, an increase of of $62,778$127,304 in accounts payable and accrued expenses.expenses, and a decrease in inventory of $118.

Reworded

For the threesix months ended MarchJune 31,30, 2025, cash used in operating activities of $68,663$86,505 resulted from a net loss of $848,783,$927,912, adjustments for for share-based compensation of $700,000$700,000, and a net increase of $80,120$141,407 in the components of working capital. The change in the components of working capital was primarily due to an increase in accounts payable and accrued expenses and a decrease in inventory.

Reworded

For the threesix months ended MarchJune 31,30, 2026, cash provided by financing activities was $39,740$70,155 consisting of contributed capital.

Reworded

For the threesix months ended MarchJune 31,30, 2025, cash provided by financing activities was $88,500 consisting of $90,000 in proceeds from the sale of common stock, off setoffset by repayments of a related party short-term loan - related party in the amount of $1,500.

Reworded

The accompanying financial statements have been prepared on a going concern basis. For the threesix months ended MarchJune 31,30, 2026, the Company had had a net loss of $102,495,$197,558, net cash used in operating activities of $39,717,$70,136, negative working capital of $273,417,$338,237, an accumulated deficit of $3,591,267$3,686,156 and stockholders’ deficit of $298,046.$362,694. These matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, to fund possible future acquisitions, and to generate profitable operations in the future. Management plans to provide for the Company’s capital requirements by continuing to issue additional equity and debt securities. The outcome of these matters cannot be predicted at this time and there are no assurances that, if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

TCRG insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

No Form 4 stock transactions in this period.

Well-known investors holding TCRG (13F)

None of the 59 investors we track reported a position in their latest 13F.

Coming soon: email alerts when TCRG files, watchlists and downloadable comparisons.